Curi RMB Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,540
| Closed | -$307K | – | 500 |
|
|
2023
Q2 | $307K | Hold |
3,540
| – | – | 0.01% | 431 |
|
|
2023
Q1 | $344K | Hold |
3,540
| – | – | 0.01% | 411 |
|
|
2022
Q4 | $366K | Buy |
3,540
+140
| +4% | +$14.5K | 0.01% | 395 |
|
|
2022
Q3 | $288K | Hold |
3,400
| – | – | 0.01% | 409 |
|
|
2022
Q2 | $282K | Hold |
3,400
| – | – | 0.01% | 417 |
|
|
2022
Q1 | $262K | Hold |
3,400
| – | – | 0.01% | 405 |
|
|
2021
Q4 | $300K | Hold |
3,400
| – | – | 0.01% | 402 |
|
|
2021
Q3 | $263K | Hold |
3,400
| – | – | 0.01% | 409 |
|
|
2021
Q2 | $284K | Hold |
3,400
| – | – | 0.01% | 418 |
|
|
2021
Q1 | $257K | Hold |
3,400
| – | – | 0.01% | 415 |
|
|
2020
Q4 | $298K | Hold |
3,400
| – | – | 0.01% | 499 |
|
|
2020
Q3 | $259K | Sell |
3,400
-738
| -18% | -$56.2K | 0.01% | 521 |
|
|
2020
Q2 | $510K | Buy |
4,138
+738
| +22% | +$91K | 0.02% | 399 |
|
|
2020
Q1 | $287K | Sell |
3,400
-14
| -0.4% | -$1.18K | 0.01% | 493 |
|
|
2019
Q4 | $289K | Hold |
3,414
| – | – | 0.01% | 548 |
|
|
2019
Q3 | $230K | Sell |
3,414
-283
| -8% | -$19.1K | 0.01% | 619 |
|
|
2019
Q2 | $317K | Hold |
3,697
| – | – | 0.01% | 588 |
|
|
2019
Q1 | $328K | Buy |
3,697
+148
| +4% | +$13.1K | 0.01% | 623 |
|
|
2018
Q4 | $302K | Sell |
3,549
-200
| -5% | -$17K | 0.01% | 712 |
|
|
2018
Q3 | $364K | Sell |
3,749
-2
| -0.1% | -$194 | 0.01% | 660 |
|
|
2018
Q2 | $353K | Buy |
3,751
+202
| +6% | +$19K | 0.01% | 659 |
|
|
2018
Q1 | $288K | Buy |
3,549
+60
| +2% | +$4.87K | 0.01% | 707 |
|
|
2017
Q4 | $311K | Buy |
+3,489
| New | +$311K | 0.01% | 684 |
|
|
2017
Q2 | – | Sell |
-6,300
| Closed | -$553K | – | 698 |
|
|
2017
Q1 | $553K | Buy |
+6,300
| New | +$553K | 0.02% | 331 |
|